Stock Information
Alkermes Plc (ALKS)
Ticker Symbol: ALKS
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $4,970.04 mil
Piotroski score: 6
PE Ratio: 19.3845
EPS (TTM): 1.4324
Revenue (TTM): $8.70 M
Dividend Yield: N/A%
ROE: 14.45%
Latest News
-
Piper Sandler Maintains Overweight on Alkermes, Lowers Price Target to $43
Tue, Mar 24, 2026 9:01 AM
-
Alkermes CEO Pops Calls 2026 a “Really Exciting Year” as Orexin Agonists Near Narcolepsy Launch
Tue, Mar 17, 2026 9:34 PM
-
Tracking Baker Brothers Portfolio - Q4 2025 Update
Tue, Mar 17, 2026 8:54 PM
Key Financials
Financial data not available
